The combination of fever, jaundice, and right upper quadrant pain (Charcot's triad) suggests cholangitis, a medical emergency requiring immediate care
Patients seeking GLP-1 therapy should rely on FDA-approved medications with established efficacy profiles, including landmark trials like STEP (semaglutide) demonstrating approximately 15% body weight reduction and SCALE (liraglutide) showing 5-8% weight reduction, along with improved glycemic control in patients with diabetes
1 This paper reignited long-dormant interest in the concept of incretins: putative gastrointestinal factors released during meal absorption that might stimulate insulin secretion in a glucose-dependent fashion
The amount of weight loss a patient experiences can vary depending on the dose of GLP-1 medication, lifestyle habits, and individual response
A STAT News investigation documented how LifeVantage became "a haven for health misinformation," with distributors trained to promote Protandim's supposed ability to treat various conditions despite lacking evidence
PloS One
